Jul 2026· Saudi Journal of Biomedical Research· Vol 11, pp. 216-223· 0 citations
TL;DR
This review explores the evolution and influence of Frugal AI on research methodology in biomedical sciences over the past decade, and critically evaluates the benefits and limitations of Frugal AI in medical research.
Abstract
Artificial intelligence [AI] has become an indispensable part of scientific and medical research, however, the exponential growth in model complexity and computational requirements has made AI adoption challenging for resource-limited settings. The concept of Frugal AI has emerged to address this gap by designing efficient, accessible, and sustainable AI systems that achieve comparable accuracy with reduced computational, financial, and environmental costs. In the context of medical research, Frugal AI enables data-driven discovery, diagnostics, and decision-making through low-cost, scalable, and adaptable methodologies. This review explores the evolution and influence of Frugal AI on research methodology in biomedical sciences over the past decade. It discusses its principles, technological innovations, and integration into experimental design, data management, and analytical frameworks. Furthermore, the paper critically evaluates the benefits and limitations of Frugal AI in medical research, highlighting its transformative role in improving accessibility, reducing bias, and fostering innovation in low-resource environments. Finally, it underscores the future perspectives of Frugal AI in achieving equitable, reproducible, and sustainable medical research worldwide.
This review evaluates the current state of AI applications in medicine, focusing on clinical knowledge encoding, molecular drug discovery, and administrative workflow optimization, while critically addressing the technical, ethical, and systemic challenges of their institutional implementation.
Aleksandra Stańczyk, Kinga Haduch, Zuzanna Michalska et al.· International Journal of Inn...· 0 citations
The findings suggest that the digitalization of the pharmaceutical industry and enhanced AI integration hold promise for developing safer and more effective therapeutic strategies, while also identifying obstacles to their widespread adoption and optimal functionality.
K. C. Panda, B. V. V. Ravi Kumar, J. Sruti et al.· Reviews on recent clinical t...· 0 citations
Artificial intelligence (AI) is rapidly transforming various sectors, with its impact on healthcare, particularly clinical laboratories, becoming increasingly profound. This narrative review explores the diverse applications of AI within clinical laboratory settings, highlighting its potential to enhance efficiency, ac...
Alhamzi Nasser Yahya· Biomedical Journal of Scient...· 0 citations
Although challenges related to data governance, interoperability, ethical oversight, and workforce preparedness remain, responsible AI adoption supported by robust regulatory frameworks will be critical for sustaining long-term value.
Upendra Nagaich· Journal of Pharmaceutical Te...· 0 citations
Since the inception of the COVID-19 pandemic, artificial intelligence has led to biomarker discovery and causal inferences for clinical outcomes from unlabeled and structured healthcare datasets. Biomedical data are produced in vast amounts and at high speeds, but remain mostly untapped in the absence of knowledge abou...